Ameriprise Financial »

Allogene Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $597k 245k 2.44
2025-03-31 $357k 245k 1.46
2024-12-31 $430k 202k 2.13
2024-09-30 $496k 177k 2.80
2024-06-30 $788k 338k 2.33
2024-03-31 $845k 189k 4.47
2023-09-30 $427k 135k 3.17
2023-06-30 $553k 111k 4.97
2023-03-31 $4.0M 808k 4.94
2022-12-31 $4.0M 641k 6.29
2022-09-30 $8.3M 771k 10.80
2022-06-30 $12M 1.0M 11.40
2022-03-31 $9.2M 1.0M 9.11
2021-12-31 $11M 715k 14.92
2021-09-30 $9.8M 382k 25.70
2021-06-30 $745k 29k 26.06
2021-03-31 $859k 24k 35.30
2020-12-31 $739k 29k 25.23
2020-09-30 $1.2M 31k 37.70
2020-06-30 $1.5M 35k 42.83